Forty Seven, Inc. $195.6 Million Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $195.6 million public offering of common stock of Forty Seven, …
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Constellation Pharmaceuticals Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $224.3 million offering of common stock of Constellation…
Davis Polk Advises Venus Medtech (Hangzhou) Inc. on Its HK$2.59 Billion (US$331.17 Million) Initial Public Offering
Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…
IVERIC bio, Inc. Common Stock and Pre-Funded Warrants Offering
Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $45 million SEC-registered common stock and pre-funded warrants offering…
Ardelyx, Inc. $144 Million Follow-On Public Offering
Davis Polk advised the joint book-running managers for the public offering of common stock by Ardelyx, Inc for gross proceeds of approximately $144 million, including the full exercise…
Millendo Therapeutics, Inc. $25 Million Offering of Common Shares
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $25 million public offering of 4,166,667 common shares of…
Kodiak Sciences Inc. $317 Million Follow-On Offering
Davis Polk advised the joint bookrunning managers and representatives of the several underwriters in connection with a $317.4 million public offering of common stock by Kodiak Sciences Inc…
Revance Therapeutics, Inc. $110 Million Common Stock Offering
Davis Polk advised the joint lead book-running managers and representatives of the several underwriters in connection with a $110.5 million SEC-registered common stock offering by…
AbbVie Inc. $30 Billion Senior Notes Offering
Davis Polk advised the initial purchasers in connection with an unregistered offering by AbbVie Inc. of $30 billion aggregate principal amount of senior notes, consisting of (i) $750…
Davis Polk Advises Shockwave Medical, Inc. on Its $90 Million Public Offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 2,481,781 shares of common stock for an aggregate price to the public of approximately $90 million. The…